Synthimed Labs, 18% 26mar2033, INR (C) (FIGI BBG01VP38Q28, INE0YL808048)
国内債券, Interest at Maturity, Senior Unsecured
国内債券, Interest at Maturity, Senior Unsecured
|
Synthimed Labs Private Limited was incorporated on 24 July, 2023. The company is engaged in providing comprehensive support for R&D programs including process development, clinical supplies, synthetic medicinal chemistry, custom synthesis, process R&D, cGMP manufacturing, analytical ...
Synthimed Labs Private Limited was incorporated on 24 July, 2023. The company is engaged in providing comprehensive support for R&D programs including process development, clinical supplies, synthetic medicinal chemistry, custom synthesis, process R&D, cGMP manufacturing, analytical development, and regulatory support. Synthimed Labs Private Limited is a wholly owned subsidiary of Synthimed Pharma.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡